Randomised Double Blind Placebo Controlled Pivotal Study to Evaluate Efficacy and Safety of rPhleum in Adult and Adolescent Patients Suffering From Rhinoconjunctivitis +/- Controlled Asthma

Trial Profile

Randomised Double Blind Placebo Controlled Pivotal Study to Evaluate Efficacy and Safety of rPhleum in Adult and Adolescent Patients Suffering From Rhinoconjunctivitis +/- Controlled Asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Nov 2014

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Asthma; Rhinoconjunctivitis; Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergopharma
  • Most Recent Events

    • 28 Jan 2014 Status changed from active, no longer recruiting to completed as reported by the European Clinical Trials Database record
    • 05 Sep 2013 Planned end date changed from 1 Aug 2013 to 1 Oct 2015 as reported by ClinicalTrials.gov.
    • 08 Mar 2013 Planned end date changed from 1 Aug 2016 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top